MicroRNA hsa-miR-29a-3p is a plasma biomarker for the differential diagnosis and monitoring of tuberculosis.


Journal

Tuberculosis (Edinburgh, Scotland)
ISSN: 1873-281X
Titre abrégé: Tuberculosis (Edinb)
Pays: Scotland
ID NLM: 100971555

Informations de publication

Date de publication:
01 2019
Historique:
received: 07 07 2018
revised: 28 11 2018
accepted: 02 12 2018
entrez: 4 2 2019
pubmed: 4 2 2019
medline: 2 7 2019
Statut: ppublish

Résumé

The diagnosis of tuberculosis (TB) continues to pose substantial public health problems. The quest for diagnostic biomarkers for TB is therefore primordial. This study aimed to evaluate the diagnostic and anti-TB treatment monitoring potentials of some selected miRNAs. Quantitative real time polymerase chain reaction and Receiver operating characteristics were used to estimate the ability of miRNAs to discriminate between healthy controls (HEC), latent (LTB) and active TB (ATB). The study showed that: hsa-miR-29a-3p, hsa-miR-155-5p and hsa-miR-361-5p were significantly upregulated in ATB compared to HEC while hsa-miR-29a-3p, and hsa-miR-361-5p were also significantly up-regulated in ATB compared to LTB (all P ≤ 0.05). MiR-29a-3p showed a good (81.37%) distinguishing performance in discriminating ATB from HEC and a good (84.35%) diagnostic performance in discriminating ATB from LTB. The performance of miR-29a-3p present in the blood in discriminating active TB from latent TB and healthy controls indicates it may be a useful biomarker for diagnosis of TB. Because this miRNA is found in blood (plasma) which is easy to collect compared to sputum it could be used in pediatric and extra-pulmonary TB cases.

Identifiants

pubmed: 30711160
pii: S1472-9792(18)30277-4
doi: 10.1016/j.tube.2018.12.001
pii:
doi:

Substances chimiques

Antitubercular Agents 0
Biomarkers 0
MIRN29a microRNA, human 0
MicroRNAs 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

69-76

Informations de copyright

Copyright © 2018. Published by Elsevier Ltd.

Auteurs

Elvis Ndukong Ndzi (EN)

Department of Biochemistry, University of Dschang, P.O. BOX 56, Dschang, Cameroon; Chantal Biya International Reference Centre (CBIRC), P.O BOX 3077, Yaounde, Cameroon; Laboratory of Animal Physiology and Health, Institute of Agricultural Research for Development (IRAD), P.O BOX 51, Bambui, Cameroon. Electronic address: elvisndzi@yahoo.com.

Céline Nguefeu Nkenfou (CN)

Chantal Biya International Reference Centre (CBIRC), P.O BOX 3077, Yaounde, Cameroon; Higher Teachers' Training College, University of Yaounde I, P.O. BOX 47, Yaounde, Cameroon. Electronic address: nkenfou@yahoo.com.

Linda Mouafo Mekue (LM)

Department of Biochemistry, University of Dschang, P.O. BOX 56, Dschang, Cameroon; Chantal Biya International Reference Centre (CBIRC), P.O BOX 3077, Yaounde, Cameroon; Laboratory of Animal Physiology and Health, Institute of Agricultural Research for Development (IRAD), P.O BOX 51, Bambui, Cameroon. Electronic address: chapdylinda2000@yahoo.fr.

Lorena Zentilin (L)

International Centre for Genetic Engineering and Biotechnology (ICGEB), Padriciano, 99, 34149, Trieste, Italy. Electronic address: lorena@icgeb.org.

Ousman Tamgue (O)

University of Cape Town, Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South Africa Medical Research Council, Immunology of Infectious Disease, Faculty of Health Sciences, Cape Town, 7925, South Africa; International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town Component, Cape Town, 7925, South Africa; Department of Biochemistry, Faculty of Sciences, University of Douala, P.O BOX 24157, Douala, Cameroon. Electronic address: tamgue2001@yahoo.fr.

Eric Walter Yone Pefura (EWY)

Jamot Hospital, Yaounde, Cameroon; Faculty of Medicine and Biomedical Science, University of Yaounde I, P.O BOX 1364, Yaounde, Cameroon. Electronic address: Pefura2002@yahoo.fr.

Jules-Roger Kuiaté (JR)

Department of Biochemistry, University of Dschang, P.O. BOX 56, Dschang, Cameroon. Electronic address: jrkuiate@yahoo.com.

Mauro Giacca (M)

International Centre for Genetic Engineering and Biotechnology (ICGEB), Padriciano, 99, 34149, Trieste, Italy. Electronic address: giacca@icgeb.org.

Alexis Ndjolo (A)

Chantal Biya International Reference Centre (CBIRC), P.O BOX 3077, Yaounde, Cameroon; Faculty of Medicine and Biomedical Science, University of Yaounde I, P.O BOX 1364, Yaounde, Cameroon. Electronic address: andjolo@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH